title: Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation.
abstract: Prior therapy with rituximab might attenuate disparate histocompatibility antigen presentation by B cells, thus decreased the risk of acute graft-versus-host disease (GVHD) and improved survival. We tested this hypothesis by comparing the outcomes of 435 B-cell lymphoma patients who received allogeneic transplantation from 1999 to 2004 in the Center for International Blood and Marrow Transplant Research database: 179 subjects who received rituximab within 6 months prior to transplantation (RTX cohort) and 256 subjects who did not receive RTX within 6 months prior to transplantation (No-RTX cohort). The RTX cohort had a significantly lower incidence of treatment-related mortality (TRM) [relative risk (RR) = 0.68; 95% confidence interval (CI), 0.47-1.0; P = 0.05], lower acute grade II-IV (RR = 0.72; 95% CI, 0.53-0.97; P = 0.03) and III-IV GVHD (RR = 0.55; 95% CI, 0.34-0.91; P = 0.02). There was no difference in the risk of chronic GVHD, disease progression or relapse. Progression-free survival (PFS) (RR = 0.68; 95% CI 0.50-0.92; P = 0.01) and overall survival (OS) (RR = 0.63; 95% CI, 0.46-0.86; P = 0.004) were significantly better in the RTX cohort. Prior RTX therapy correlated with less acute GVHD, similar chronic GVHD, less TRM, better PFS and OS.
authors.affiliation: Blood and Marrow Transplantation Program, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA. ratanath@karmanos.org
authors.forename: Voravit
authors.initials: V
authors.lastname: Ratanatharathorn
authors.forename: Brent
authors.initials: B
authors.lastname: Logan
authors.forename: Dan
authors.initials: D
authors.lastname: Wang
authors.forename: Mary
authors.initials: M
authors.lastname: Horowitz
authors.forename: Joseph P
authors.initials: JP
authors.lastname: Uberti
authors.forename: Olle
authors.initials: O
authors.lastname: Ringden
authors.forename: Robert Peter
authors.initials: RP
authors.lastname: Gale
authors.forename: Hanna
authors.initials: H
authors.lastname: Khoury
authors.forename: Mukta
authors.initials: M
authors.lastname: Arora
authors.forename: Stephen
authors.initials: S
authors.lastname: Spellman
authors.forename: Corey
authors.initials: C
authors.lastname: Cutler
authors.forename: Joseph
authors.initials: J
authors.lastname: Antin
authors.forename: Martin
authors.initials: M
authors.lastname: Bornhaüser
authors.forename: Gregory
authors.initials: G
authors.lastname: Hale
authors.forename: Leo
authors.initials: L
authors.lastname: Verdonck
authors.forename: Mitchell
authors.initials: M
authors.lastname: Cairo
authors.forename: Vikas
authors.initials: V
authors.lastname: Gupta
authors.forename: Steven
authors.initials: S
authors.lastname: Pavletic